 |
| 2009BioTaiwan |
|
|
 |
| Visitor
Info |
|
|
|
| ShowReport |
|
|
|
|
|
|
| |
|
| |
| |
|
|
|
 |
| 2008 Taiwan Vaccine Development Conference |
|
| Conference： |
2008 Taiwan Vaccine Development Conference |
| Date / Time： |
July 24th, 2008 8:45 A.M. – 12:15 P.M. |
| Venue： |
Room 3, Taipei World Trade Center Hall 1
5 Hsin-Yi Rd., Sec 5, Taipei, Taiwan, 11002, R.O.C. |
| Language： |
English/Mandarin |
| Registration Fee： |
Free |
| Organizer： |
Center for Disease Control, R.O.C.
Taiwan Bio Industry Organization |
| Co-Organizer： |
International Research and Pharmaceutical Manufacturers Association (IRPMA) |
| Apply Now |
| |
Conference Agenda |
|
Time |
Topic |
Moderator/Speaker |
08:45 ~ 09:00 |
Registration
|
09:00 ~ 09:05 |
Welcome & Opening Remarks
|
Conference Chairman: Dr. Steve H. S. Kuo , Director, Center for Disease Control |
|
【Session I】
Moderator: Dr. Hong-Jen Chang
Vice-Chairman, Taiwan Bio Industry Organization
|
|
09:05 ~ 09:35 |
Vaccines: A view from the industry |
Dr. Michel Klein, Vice CEO, AmVac Company (Switzerland) (to be invited) |
|
09:35 ~ 10:05 |
A reflection and new determination – Site-specific Vaccines and Immunotherapeutics
|
Dr. Wang Chang-Yi , Chairman, United Biomedical, Inc. Asia |
10:05 ~ 10:15 |
Break |
【Session II】
Moderator: Dr. Pele Choi-Sing Chong
Director, Vaccine R&D Center, National Health Research Institutes |
|
10:15 – 10:45 |
Development of a Hemagglutinin-Based DNA Vaccine against H5N1 virus with NKT stimulatory glycolipids as adjuvants
|
Dr. Alice L. Yu
Associate Director, Genomics Research Center, Academia Sinica
|
|
10:45 ~ 11:15 |
The Trend and Development of Taiwan Vaccine Industry
|
Dr. Sy-Dar Wang, Chief Technical Officer, Adimmune Corporation |
|
11:15 ~ 11:45 |
Therapeutic vaccine for Asian-specific HPV associated cancer
|
Dr. Levent S.J. Liu
Assistant Investigator, Vaccine R&D Center, National Health Research Institutes
|
|
11:45 ~ 12:15 |
Development of Enterovirus 71 Vaccine
|
Dr. Min-Shi Lee, Associate Investigator, Vaccine Research and Development Center NHRI |
|
|
| |
| Apply Now |
|
| |
| |
| |
| |
| |
|
| |
|
|
|
